Literature DB >> 9279987

Indirect hemagglutination antibodies against Burkholderia pseudomallei in normal blood donors and suspected cases of melioidosis in Malaysia.

A Norazah1, M Y Rohani, P T Chang, A G Kamel.   

Abstract

Interpretation of the indirect hemagglutination test (IHA) for melioidosis in endemic areas is difficult because of the presence of antibodies in apparently healthy individuals. Fifty-three out of 200 healthy blood donors in Malaysia showed positive antibody titers (> or = 1 : 40) against Burkholderia pseudomallei. Seven percent had an IHA titer of 1 : 40, 11% had an IHA titer of 1 : 80 while 8.5% had a titer > or = 1 : 160. Out of 258 sera sent for melioidosis serology, 7% of the patients had an IHA titer of 1 : 40, 9% had an IHA titer of 1 : 80 while 20% had an IHA titer of > or = 1 : 160. If a titer of > or = 1 : 80 is taken as cut off point for positivity, 29% of the patients had positive melioidosis serology. Increasing the positivity threshold may jeopardize the sensitivity of the test. A more specific and sensitive test is needed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9279987

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  2 in total

1.  Accuracy of enzyme-linked immunosorbent assay using crude and purified antigens for serodiagnosis of melioidosis.

Authors:  Narisara Chantratita; Vanaporn Wuthiekanun; Aunchalee Thanwisai; Direk Limmathurotsakul; Allen C Cheng; Wirongrong Chierakul; Nicholas P J Day; Sharon J Peacock
Journal:  Clin Vaccine Immunol       Date:  2006-11-08

2.  Serum From Melioidosis Survivors Diminished Intracellular Burkholderia pseudomallei Growth in Macrophages: A Brief Research Report.

Authors:  Panjaporn Chaichana; Barbara Kronsteiner; Patpong Rongkard; Prapit Teparrukkul; Direk Limmathurotsakul; Narisara Chantratita; Nicholas P J Day; Helen A Fletcher; Susanna J Dunachie
Journal:  Front Cell Infect Microbiol       Date:  2020-08-26       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.